Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy.

Tumati V, Mathur S, Song K, Hsieh JT, Zhao D, Takahashi M, Dobin T, Gandee L, Solberg TD, Habib AA, Saha D.

Int J Oncol. 2013 May;42(5):1613-9. doi: 10.3892/ijo.2013.1858. Epub 2013 Mar 19.

2.

Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.

Kong Z, Raghavan P, Xie D, Boike T, Burma S, Chen D, Chakraborty A, Hsieh JT, Saha D.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1210-8. doi: 10.1016/j.ijrobp.2010.06.019.

PMID:
20970033
3.

DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor.

Yu L, Tumati V, Tseng SF, Hsu FM, Kim DN, Hong D, Hsieh JT, Jacobs C, Kapur P, Saha D.

Neoplasia. 2012 Dec;14(12):1203-12.

4.

Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.

Kong Z, Xie D, Boike T, Raghavan P, Burma S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT, Saha D.

Cancer Res. 2010 Apr 1;70(7):2829-39. doi: 10.1158/0008-5472.CAN-09-2919. Epub 2010 Mar 23.

5.

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.

Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD.

J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. Epub 2007 Dec 11.

6.

Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.

Johannsen M, Thiesen B, Gneveckow U, Taymoorian K, Waldöfner N, Scholz R, Deger S, Jung K, Loening SA, Jordan A.

Prostate. 2006 Jan 1;66(1):97-104.

PMID:
16114060
7.

Neoadjuvant androgen withdrawal prior to external radiotherapy for locally advanced adenocarcinoma of the prostate.

Hara I, Miyake H, Yamada Y, Takechi Y, Hara S, Gotoh A, Fujisawa M, Okada H, Arakawa S, Soejima T, Sugimura K, Kamidono S.

Int J Urol. 2002 Jun;9(6):322-8; discussion 328.

8.

Ultrasound guided combined cryoablation and microencapsulated 5-Fluorouracil inhibits growth of human prostate tumors in xenogenic mouse model assessed by luminescence imaging.

Le Pivert P, Haddad RS, Aller A, Titus K, Doulat J, Renard M, Morrison DR.

Technol Cancer Res Treat. 2004 Apr;3(2):135-42.

PMID:
15059019
9.

Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.

Hillman GG, Maughan RL, Grignon DJ, Yudelev M, Rubio J, Tekyi-Mensah S, Layer A, Che M, Forman JD.

Clin Cancer Res. 2001 Jan;7(1):136-44.

10.

Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.

Chan HH, Chu TH, Chien HF, Sun CK, Wang EM, Pan HB, Kuo HM, Hu TH, Lai KH, Cheng JT, Tai MH.

BMC Gastroenterol. 2010 Jul 22;10:83. doi: 10.1186/1471-230X-10-83.

12.
13.

In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T.

Walker P, Provent P, Tizon X, Créhange G, Duchamp O, Brunotte F, Genne P.

Acta Radiol. 2013 Feb 1;54(1):121-6. doi: 10.1258/ar.2012.120232. Epub 2012 Oct 18.

PMID:
23081956
14.

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

Gandhi N, Wild AT, Chettiar ST, Aziz K, Kato Y, Gajula RP, Williams RD, Cades JA, Annadanam A, Song D, Zhang Y, Hales RK, Herman JM, Armour E, DeWeese TL, Schaeffer EM, Tran PT.

Cancer Biol Ther. 2013 Apr;14(4):347-56. doi: 10.4161/cbt.23626. Epub 2013 Jan 28.

15.

CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.

Chen Y, DeWeese T, Dilley J, Zhang Y, Li Y, Ramesh N, Lee J, Pennathur-Das R, Radzyminski J, Wypych J, Brignetti D, Scott S, Stephens J, Karpf DB, Henderson DR, Yu DC.

Cancer Res. 2001 Jul 15;61(14):5453-60.

16.

Radiation therapy for the treatment of locally advanced and metastatic prostate cancer.

Thurman SA, Ramakrishna NR, DeWeese TL.

Hematol Oncol Clin North Am. 2001 Jun;15(3):423-43. Review.

PMID:
11525289
17.

MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment.

Mu Z, Ma CM, Chen X, Cvetkovic D, Pollack A, Chen L.

Phys Med Biol. 2012 Jan 21;57(2):535-45. doi: 10.1088/0031-9155/57/2/535.

PMID:
22217916
18.

Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model.

Hillman GG, Wang Y, Kucuk O, Che M, Doerge DR, Yudelev M, Joiner MC, Marples B, Forman JD, Sarkar FH.

Mol Cancer Ther. 2004 Oct;3(10):1271-9.

19.

Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis.

Sklar GN, Eddy HA, Jacobs SC, Kyprianou N.

J Urol. 1993 Nov;150(5 Pt 1):1526-32.

PMID:
8411447
20.

Pushing the limits of radiation therapy for prostate cancer: where do we go next?

Mishra MV, Showalter TN.

Semin Oncol. 2013 Jun;40(3):297-307. doi: 10.1053/j.seminoncol.2013.04.005. Review.

PMID:
23806495
Items per page

Supplemental Content

Write to the Help Desk